SCHEMBL18529451

SCHEMBL18529451

CON(C)C(=O)c1ccc(Cl)nc1C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 2/20 0.47
ATF1 P18846 5/20 0.40
NFKB1 P19838 5/20 0.40
MLYCD O95822 1/20 0.40
TUBB4A P04350 2/20 0.39
TUBB P07437 2/20 0.39
TUBA3C P0DPH7 2/20 0.39
TUBA1B P68363 2/20 0.39
TUBA4A P68366 2/20 0.39
TUBB4B P68371 2/20 0.39
TUBB3 Q13509 2/20 0.39
TUBB2A Q13885 2/20 0.39
TUBB8 Q3ZCM7 2/20 0.39
TUBA3E Q6PEY2 2/20 0.39
TUBA1A Q71U36 2/20 0.39
TUBA1C Q9BQE3 2/20 0.39
TUBB6 Q9BUF5 2/20 0.39
TUBB2B Q9BVA1 2/20 0.39
TUBB1 Q9H4B7 2/20 0.39
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29663634 0.80 TUBB4A (0.43) MLYCDTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3700292 0.80 TUBB4A (0.43) MLYCDTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL18529452 0.80 LIPE (0.43) ATF1NFKB1MEN1KMT2AGAA
SCHEMBL30751960 0.79 XPO1 (0.55) XPO1ATF1NFKB1TUBB4ATUBB
SCHEMBL28830749 0.79 XPO1 (0.55) XPO1ATF1NFKB1TUBB4ATUBB
SCHEMBL26179779 0.79 TUBB4A (0.42) NFKB1MLYCDTUBB4ATUBBTUBA3C
SCHEMBL20808527 0.78 XPO1 (0.60) XPO1ATF1NFKB1MEN1KMT2A
SCHEMBL3834955 0.78 TUBB4A (0.41) MLYCDTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3778708 0.77 TUBB4A (0.46) MLYCDTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20303639 0.77 MLYCD (0.40) XPO1MLYCDTUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137538-B Triazole derivatives, intermediates thereof and their use as fungicides 拜耳作物科学股份公司 2021-02-26 CN disclosed
US-20200095223-A1 NOVEL TRIAZOLETHIONE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-03-26 US disclosed
US-20200095223-A1 NOVEL TRIAZOLETHIONE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-03-26 US disclosed
US-20200045967-A1 NOVEL TRIAZOLE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-02-13 US disclosed
US-20200045967-A1 NOVEL TRIAZOLE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-02-13 US disclosed
US-20200029563-A1 NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2020-01-30 US disclosed
US-20200029563-A1 NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2020-01-30 US disclosed
EP-3519404-A1 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES AS FUNGICIIDES Bayer CropScience Aktiengesellschaft (DE) 2019-08-07 EP disclosed
US-20180235223-A1 TRIAZOLE DERIVATIVES, INTERMEDIATES THEREOF AND THEIR USE AS FUNGICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-08-23 US disclosed
WO-2018145933-A1 TRIAZOLETHIONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2018-08-16 WO disclosed
WO-2018145921-A1 COMPOSITION FOR CONTROLLING HARMFUL MICROORGANISMS COMPRISING 1 -(PHENOXY-PYRIDINYL)-2-(1,2,4-TRIAZOL-1 -YL)-ETHANOL DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2018-08-16 WO disclosed
EP-3334718-A1 TRIAZOLE DERIVATIVES, INTERMEDIATES THEREOF AND THEIR USE AS FUNGICIDES Bayer CropScience Aktiengesellschaft (DE) 2018-06-20 EP disclosed
WO-2018060088-A1 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES AS FUNGICIIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-04-05 WO disclosed
WO-2017029179-A1 TRIAZOLE DERIVATIVES, INTERMEDIATES THEREOF AND THEIR USE AS FUNGICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-02-23 WO disclosed
WO-2017029179-A1 TRIAZOLE DERIVATIVES, INTERMEDIATES THEREOF AND THEIR USE AS FUNGICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180235223-A1 TRIAZOLE DERIVATIVES, INTERMEDIATES THEREOF AND THEIR USE AS FUNGICIDES CYP51A1, ERG28, CYP4Z1 XPO1 2356/4885ATF1 1980/4885NFKB1 2827/4885
US-20200045967-A1 NOVEL TRIAZOLE DERIVATIVES CYP51A1, ERG28, SBK3 XPO1 2888/4885ATF1 447/4885NFKB1 1004/4885
US-20200095223-A1 NOVEL TRIAZOLETHIONE DERIVATIVES CYP51A1, SBK3, TST XPO1 2665/4885ATF1 270/4885NFKB1 1834/4885
US-20200029563-A1 NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES PIP5K1B, PIP5K1A, PIP5K1C XPO1 2806/4885ATF1 717/4885NFKB1 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.